Posted in | News

COPT Buys 474,000 Square Foot Office Tower for Canton Crossing Unit in Maryland

Corporate Office Properties Trust (COPT) (NYSE:OFC) announced today the acquisition of a 474,000 square foot office tower, a parking lot, a utility distribution center, four waterfront lots and riparian rights, all part of the Canton Crossing planned unit development in Baltimore, Maryland.

The waterfront lots are approved for 500,000 square feet of office, 150,000 square feet of retail, a 450 room hotel and a marina. The office tower is 91% leased with CareFirst as the largest tenant at 34%. The financial details of the transaction will be disclosed on our third quarter earnings conference call scheduled for Thursday, October 29, 2009 at 11:00 a.m. Eastern Time. Detailed information to access the conference call will be provided in our third quarter earnings press release to be issued Wednesday, October 28, 2009.

“We are pleased to add this acquisition to our portfolio,” stated Randall M. Griffin, President and Chief Executive Officer for Corporate Office Properties Trust. “These are excellent, high quality assets that COPT has acquired at a fair price with additional upside resulting from the potential for future development. Canton Crossing, in the Canton area of Baltimore, is in close proximity to I-95 and is well positioned to capture future growth along the Baltimore waterfront,” he added.

Source: http://www.copt.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.